Journal of Oncology Pharmacy Practice

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Register here to gain access to SAGE's 500+ Journals Online

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Lemos, M. L
Right arrow Search for Related Content
PubMed
Right arrow Articles by de Lemos, M. L
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Oncology Pharmacy Practice, Vol. 10, No. 3, 141-144 (2004)
DOI: 10.1191/1078155204jp126oa

Rationing costly treatments: can it be fair?

Mário L de Lemos, PharmD, MRPharmS

British Columbia Cancer Agency, Vancouver, BC, Canada

Healthcare resources are finite and rationing is common. Fair distribution assumes that equals are treated equally and unequals are treated unequally, based on morally relevant differences such as the needs of and likely benefits to the patients. Applying these considerations in practice is complex. A case is described to illustrate the ethical issues raised by patients’ requests to pay for an expensive drug treatment.

Key Words: health care ethics • health priorities • medical ethics • resource allocation • social justice


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?